Updated: 10/10/2016

Renal Osteodystrophy

Topic
Review Topic
0
0
Questions
6
0
0
Evidence
1
0
0
Videos
2
https://upload.orthobullets.com/topic/9030/images/renal od histo.jpg
https://upload.orthobullets.com/topic/9030/images/renal od patho frac.jpg
https://upload.orthobullets.com/topic/9030/images/looser zones.jpg
https://upload.orthobullets.com/topic/9030/images/looserzone2.jpg
https://upload.orthobullets.com/topic/9030/images/brown.jpg
https://upload.orthobullets.com/topic/9030/images/sclerosis.jpg
Introduction
  • Definition
    • a spectrum of disease seen in patients with chronic renal disease.
    • characterized by bone mineralization deficiency due to electrolyte and endocrine abnormalities 
    • common cause of hypocalcemia
  • Pathophysiology
    • hypocalcemia
      • due to the inability of the damaged kidney to convert vitamin D3 to calcitrol (the active form)
      • because of phosphate retention (hyperphosphatemia)
    • hyperparathyroidism and secondary hyperphosphatemia
      • caused by hypocalcemia and lack of phosphate excretion by damaged kidney
    • uremia related phosphate retention 
      • is a key pathological step
  • Associated conditions
    • orthopaedic manifestations
      • osteomalacia (adults) and growth retardation (children)
      • AVN
      • tendinitis and tendon rupture
      • carpal tunnel syndrome
        • deposition of amyloid (β2 microglobulin)
      • pathologic fracture  
        • from brown tumors (hyperparathyroidism) or amyloid deposits
      • osteomyelitis and septic arthritis
Classification
  • High-turnover renal bone disease (high PTH disease)
    • chronically elevated phosphate leads to secondary hyperparathyroidism 
      • hyperphosphatemia lowers serum Ca, stimulating PTH
      • phosphorus impairs renal 1α-hydroxylase, reducing 1,25(OH)2 vitamin D3 production
      • phosphorus retention directly stimultes PTH production
      • hyperplasia of chief cells of parathyroid gland
    • associated lab values
      •  decreased calcium, increased serum phosphate, increased alkaline phosphate, increased parathyroid hormone
  • Low turnover renal bone disease (normal PTH disease)
    • characterized by lack of secondary hyperparathyroidism
    • normal levels of PTH with characteristic bone lesions marked by low levels of bone formation
    • excess deposition of aluminium into bone affects bone mineralization
      • impairs differentiation of precursors into osteoblasts, and osteoblast proliferation
      • impairs PTH release from parathyroid gland
      • disrupts mineralization
Presentation
  • Symptom
    • weakness
    • bone pain
    • pathological fracture  
      • commonest complication
    • skeletal deformity
    • symptoms of hypocalcemia
      • abdominal pain
      • muscle cramps
      • dyspnea
      • convulsions/seizures
      • mental status changes
  • Physical exam
    • provocative tests for tetany
      • Trousseau's Sign post
        • carpalpedal spasm after blood pressure readings
      • Chvostek's Sign post
        • facial muscle contractions after tapping on the facial nerve
 Imaging
  •  Radiographs 
    • findings
      • Looser's zones  
      • brown tumor  
      • osteosclerosis       
        • from mineralization of osteomalacic bone 
        • rugger jersey spine  
      • widened growth plate and zone of provisional calcification (children)
      • varus deformity of the femurs (children) 
      • fracture  
      • soft-tissue calcification  
      • osteopenia
  • CT
    • osseous resorption  
Evaluation
  • Histology
    • thinned trabeculae 
    • amyloid stains pink on Congo red stain
  • Labs
    • decreased serum calcium
    • increased serum phos
    • increased PTH
 
Treatment
  • Nonoperative
    • treat underlying renal condition or relieve urologic obstruction
 

Please rate topic.

Average 3.8 of 21 Ratings

Thank you for rating! Please vote below and help us build the most advanced adaptive learning platform in medicine

The complexity of this topic is appropriate for?
How important is this topic for board examinations?
How important is this topic for clinical practice?
Questions (6)

(OBQ12.37) Which of the following series of lab values is most consistent with a diagnosis of high turnover renal osteodystrophy? Review Topic

QID: 4397
1

Decreased calcium, increased serum phosphate, increased alkaline phosphatase, increased parathyroid hormone

57%

(2122/3747)

2

Decreased calcium, decreased serum phosphate, increased alkaline phosphatase, increased parathyroid hormone

19%

(709/3747)

3

Increased calcium, normal serum phosphate, increased alkaline phosphatase, normal parathyroid hormone

8%

(312/3747)

4

Decreased calcium, increased serum phosphate, normal alkaline phosphatase, decreased parathyroid hormone

4%

(152/3747)

5

Increased calcium, normal serum phosphate, normal or high alkaline phosphatase, increased parathyroid hormone

11%

(395/3747)

ML 4

Select Answer to see Preferred Response

PREFERRED RESPONSE 1
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK

(OBQ08.114) What laboratory findings would you expect to find in a patient newly diagnosed with renal osteodystrophy?
Review Topic

QID: 500
1

Decreased PTH secretion, hypophosphatemia, and hypocalcemia

4%

(47/1240)

2

Increased PTH secretion, hyperphosphatemia, and hypocalcemia

71%

(877/1240)

3

Decreased PTH secretion, hypophosphatemia, and hypercalcemia

6%

(70/1240)

4

Increased PTH secretion, hyperphosphatemia, and hypercalcemia

15%

(180/1240)

5

Hypophosphatemia and hypocalcemia

5%

(59/1240)

ML 2

Select Answer to see Preferred Response

PREFERRED RESPONSE 2

(OBQ07.22) You are seeing a dialysis patient for a fragility fracture. This patient also carries a diagnosis of renal osteodystrophy. What is the key pathophysiological step that is responsible for his osteomalacia? Review Topic

QID: 683
1

Altered parathyoid hormone receptor sensitivity

24%

(360/1503)

2

Chronic metabolic alkalosis

4%

(56/1503)

3

Chronic imbalance of electrolytes during dialysis

4%

(67/1503)

4

Uremia related phosphate retention

63%

(941/1503)

5

Tyrosine kinase receptor phosphorylation of the improper intracellular signalling proteins

5%

(74/1503)

ML 3

Select Answer to see Preferred Response

PREFERRED RESPONSE 4
ARTICLES (3)
VIDEOS (2)
Topic COMMENTS (5)
Private Note